Oral Answers to Questions

Saqib Bhatti Excerpts

Tuesday 17th October 2023 Commons Chamber

[Will Quince]

I thank my hon. Friend for her question, which is better directed at the BMA. However, she is right to suggest that we are taking action on minimum service level legislation. We recognise that industrial action means that services are under increased pressure, with appointments and treatments being cancelled because of the strikes. The NHS is taking action, prioritising urgent and cancer care, and will of course continue to do so. It will do its best to maintain appointments and elective procedures, wherever possible, but she is right to say that these strikes and the actions of the BMA are having a devastating impact on patients.

[Saqib Bhatti (Meriden) (Con)]

My constituent Elaine Lynch was diagnosed with stage 4 lung cancer in September 2021. The drug she needs, Enhertu, is available free on the NHS to treat breast cancer, but not lung cancer, so it is costing my constituent £10,000 a month to get the treatment, without which she will die. The public petition on this matter has received more than 200,000 signatures, so it is very much in the public interest. As the company Daiichi Sankyo does not offer the drug on compassionate grounds, will the Minister meet me to see how we can make this drug available for Elaine as soon as possible, because this is literally a matter of life or death?

[Will Quince]

I have huge sympathy and empathy with the case that my hon. Friend raises. The National Institute for Health and Care Excellence is rightly independent, and strict and robust processes are in place on drug repurposing and clinical trials. Nevertheless, I would of course be happy to meet him to see what can be done.